美股市場個股詳情
DCPH Deciphera Pharmaceuticals
- 25.280
- +10.630+72.56%
收盤價 04/29 16:00 (美東)
- 25.200
- -0.080-0.32%
盤後 19:45 (美東)
20.79億總市值-11039市盈率TTM
25.400最高價25.165最低價5072.45萬股成交量25.200今開14.650昨收12.75億成交額118.78%換手率虧損市盈率(靜)8222.60萬總股本25.40052周最高5.92市淨率10.80億流通值9.90052周最低--股息TTM4270.49萬流通股71.110歷史最高--股息率TTM1.60%振幅6.510歷史最低25.135平均價1股每手
關於Deciphera Pharmaceuticals公司
Deciphera Pharmaceuticals, Inc.是一家生物製藥公司，致力於發現、開發和爲癌症患者提供重要的新藥治療。該公司設計了一種候選藥物DCC-2618，用於抑制驅動胃腸道間質瘤、晚期系統性肥大細胞增多症、膠質瘤和其他實體瘤等癌症的突變或擴增的KIT和PDGFRa激酶的全譜。
公司介紹
公司代碼DCPH
公司名稱Deciphera Pharmaceuticals
上市日期2017/09/28
發行價格17.00
成立日期2003
CEOMr. Steven L. Hoerter
所屬市場納斯達克
員工數量355
證券類型海外普通股
年結日12-31
公司地址200 Smith Street
城市Waltham
省份麻塞諸塞州
國家美國
郵編02451
電話1-781-209-6400
董事高管
- 姓名
- 職務
- 年薪
- Steven L. Hoerter
- Director, President and Chief Executive Officer
- 601.07萬
- Dr. Matthew L. Sherman, M.D.
- Executive Vice President and Chief Medical Officer
- 212.89萬
- Daniel C. Martin
- Senior Vice President and Chief Commercial Officer
- 157.89萬
- Thomas P. Kelly
- Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer
- 203.08萬
- Dashyant Dhanak
- Executive Vice President and Chief Scientific Officer
- --
- Jama Pitman
- Senior Vice President, Regulatory, Quality and Portfolio Management
- --
- Ron Squarer
- Chairman of the Board
- 40.33萬
- Frank S. Friedman
- Independent Director
- 38.23萬
- John R. Martin
- Independent Director
- 38.86萬
- Dennis L. Walsh
- Independent Director
- 38.61萬
- Dr. Edward J. Benz, Jr,M.D.
- Independent Director
- 39.61萬
- Dr. James A. Bristol, PhD
- Independent Director
- 41.48萬
- Patricia L. Allen
- Independent Director
- 39.86萬
- Dr. Susan L. Kelley, M.D.
- Independent Director
- 39.61萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅